 |
 Video: What is a Stock Split?
|
|
|
| Beyond Air is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit® platform) capable of generating NO from ambient air. The LungFit® platform can generate NO for delivery to a patient's lungs directly or via a ventilator. LungFit® can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. LungFit® can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections via delivery through a breathing mask or similar apparatus. According to our Beyond Air stock split history records, Beyond Air has had 0 splits. | |
|
Beyond Air (XAIR) has 0 splits in our Beyond Air stock split history database.
Looking at the Beyond Air stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beyond Air shares, starting with a $10,000 purchase of XAIR, presented on a split-history-adjusted basis factoring in the complete Beyond Air stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/13/2018 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$3.00 |
|
| End price/share: |
$1.21 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-59.67% |
|
| Average Annual Total Return: |
-14.34% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,033.60 |
|
| Years: |
5.87 |
|
|
|
|
|
